Adult mild encephalitis with reversible splenial lesion associated with delirious mania: a case report by Bellani, Marcella et al.
Frontiers in Psychiatry | www.frontiersin.or
Edited by:
Diogo Telles-Correia,
University of Lisbon,
Portugal
Reviewed by:
Steven Mark Miller,
Monash University,
Australia
Yasuo Terao,
Kyorin University,
Japan
*Correspondence:
Marcella Bellani
marcella.bellani@univr.it
Specialty section:
This article was submitted to
Neuroimaging and Stimulation,
a section of the journal
Frontiers in Psychiatry
Received: 01 August 2019
Accepted: 31 January 2020
Published: 26 February 2020
Citation:
Bellani M, Zanette G, Zovetti N,
Barillari M, Del Piccolo L and
Brambilla P (2020) Adult Mild
Encephalitis With Reversible
Splenial Lesion Associated With
Delirious Mania: A Case Report.
Front. Psychiatry 11:79.
doi: 10.3389/fpsyt.2020.00079
CASE REPORT
published: 26 February 2020
doi: 10.3389/fpsyt.2020.00079Adult Mild Encephalitis With
Reversible Splenial Lesion
Associated With Delirious Mania:
A Case Report
Marcella Bellani1,2*, Giovanni Zanette2, Niccolò Zovetti 3, Marco Barillari 4,
Lidia Del Piccolo2 and Paolo Brambilla5,6
1 Section of Psychiatry, AOUI, Verona, Italy, 2 Department of Neurosciences, Biomedicine and Movement, University of
Verona, Verona, Italy, 3 University of Verona, Verona, Italy, 4 Department of Diagnostics and Public Health, University of
Verona, Verona, Italy, 5 Department of Neurosciences and Mental Health, IRCCS Ca ‘Granda Foundation Major Hospital
Polyclinic, Milan, Italy, 6 Department of Pathophysiology and Transplantation, Faculty of Medicine and Surgery, University of
Milan, Milan, Italy
Mild encephalitis with reversible splenial lesion is a rare clinic-radiological entity presenting
with neurological and neuropsychiatric symptoms associated with cerebral lesion/s.
Delirious mania is a severe psychiatric syndrome characterized by acute onset of
delirium, excitement, and psychosis with a high mortality rate. In this paper, we present a
case report of mild encephalitis with reversible splenial lesion clinically presenting as delirious
mania and evolving into life-threatening multi-organ failure. The patient was treated with
aripiprazole and benzodiazepine with poor effect and, after 4 days, the patient's condition
signiﬁcantly worsened requiring transfer to the intensive care unit where deep sedation with
propofol was started. Our ﬁndings are in contrast with the traditional literature description of
self-resolving and harmless mild encephalitis with reversible splenial lesion. Moreover, rapid
clinical recovery and the progressive improvement of psychiatric symptoms after deep
sedation with propofol in this case—considering propofol's neuroprotective and anti-
inﬂammatory effects—supports the notion of propofol-mediated deep sedation for the
treatment of severe manic symptoms associated with life-threatening conditions. Little is
known about neural markers of the manic state, and the corpus callosum has been
described to be involved in bipolar disorder. Abnormalities in this structure may represent a
marker of vulnerability for this disorder.
Keywords: encephalitis, manic state, neuroimaging, deep sedation, propofolBACKGROUND
Mild encephalitis with reversible splenial lesions (MERS) is a rare clinic-radiological entity, ﬁrst
identiﬁed in 2004 (1), deﬁned by the presence of clinical neurological and neuropsychiatric symptoms
associated with a single lesion in the midline of the splenium of the corpus callosum (SCC) (MERS
type I) and, in some cases lesions with similar radiological aspects in the white matter of the cerebral
hemispheres (MERS type II) (2). According to the literature, MERS seems to be more common ing February 2020 | Volume 11 | Article 791
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consciousness, seizures (more common in children) and headache
(more common in adults) (2). The MERS diagnostic criteria are,
according to Hoshino et al. (4): (i) clinical onset associated with
neuropsychiatric symptoms, such as impaired consciousness
within 1 week after fever onset; (ii) complete recovery without
sequelae, mostly within 10 days after the onset of neuropsychiatric
symptoms; (iii) high-signal intensity lesion in the SCC; (iv)
involvement of the entire corpus callosum and bilateral cerebral
white matter with symmetrical pattern may also occur; and (iv)
lesion disappearing within 1 week, with no residual signal changes
or atrophy. For MERS, typical magnetic resonance imaging
markers are: (i) high signal intensity in T2 weighted images; (ii)
decreased apparent diffusion coefﬁcient (ADC) value of the lesion;
and (iii) hyper-isointense signals on T1 weighted images (2).
Furthermore, Tsuji et al. (5) report similar radiological features
in a patient without neurological signs (5). Previous studies
identiﬁed that MERS could be triggered by infections, such as
inﬂuenza virus, rotavirus, mumps virus, mycoplasma pneumonia,
and legionella pneumonia (2), and adverse drug reactions (ADR),
particularly in patients with malignant neuroleptic syndrome (6–
8), lithium intoxication (9), or antiepileptic drug withdrawal (10,
11). To our knowledge, the present case is only the second case
(10) of MERS associated with mania and the ﬁrst presenting with
delirious mania.
Delirious mania is a severe psychiatric syndrome
characterized by acute onset of delirium, excitement, and
psychosis. It was initially described by Calmeil in 1832 as an
“uncommon but life-threatening psychosis with extreme
hyperactivity and mounting fear fading to stuporous
exhaustion” (12). Different terms have been used to name
delirious mania, e.g., lethal catatonia and malignant catatonia. It
is a rare syndrome, possibly underestimated with several authors
suggesting that as many as 15%–20% of all acutely manic patients
show signs of delirium (12). Patients with this syndrome experience
signiﬁcant morbidity and mortality risk (12–14) if not quickly
treated. The syndrome is often accompanied by signs of organ
failure which are often unable to be managed in an ordinary
psychiatric unit. Delirious mania is marked by acute onset of
excitement, grandiosity, emotional lability, delusions, and
insomnia (typical features of mania), and disorientation and
altered consciousness (typical features of delirium). Bond (15)
outlined six criteria that may distinguish delirious mania: (i)
acute onset; (ii) presence of hypomania or mania; (iii) developing
signs and symptoms of delirium; (iv) history of mania or
depression; (v) family history of affective disorder; and (vi)
responsivity to treatment for mania. Furthermore, patients may
show a typical resistance to common pharmacological treatments at
usual doses. Karmacharya et al. (12) suggested that the deﬁnitive
treatment for this condition is electroconvulsive therapy (ECT) and
when ECT is not available, high-dose benzodiazepines should be
used. There is presently, however, no clear consensus on which
clinical features are associated with delirious mania and which
treatments are effective (14). Additionally, deep sedation in an
intensive care unit may represent an option, especially in the acute
phase of the disorder. Few articles describe the use of deep sedation
as a treatment for refractory mania or delirious mania (16–18).Frontiers in Psychiatry | www.frontiersin.org 2CASE REPORT
A 37-year-old man, with a history of schizoid personality
disorder and previous brief psychotic episodes, was admitted to
the Psychiatric Department (AOUI Verona) for a rapid onset of
psychomotor agitation associated with delusional ideation,
confusion, aggressive behavior, and mood elevation with
dysphoria. These symptoms apparently started 5 days before,
rapidly worsening during the 12 h before admission. The patient
was on stable treatment with aripiprazole 10 mg daily and 2
weeks before the described episode the dose of aripiprazole was
reduced to 7.5 mg daily. Combined antipsychotic and
benzodiazepine treatment was immediately started with poor
effect, making physical restraint necessary.
During the ﬁrst days the patient developed physical
alterations such as high blood pressure, tachycardia, elevation
of body temperature (BT) and signiﬁcant elevation of creatine
phosphokinase (CPK). Levels of ammonia, antinuclear
antibodies (ANA), (extractable nuclear antigens (ENA), anti-
DNA autoantibodies, C3, C4, erythrocyte sedimentation rate
(ESR) and procalcitonin did not reveal any alteration. The only
altered inﬂammation index found was C-Reactive Protein (CRP),
which reached levels of 50 mg/L. Blood culture and uroculture
were negative.
On day 3, a brain computed tomography (CT) and an MRI
examination were performed in the Radiology Department of
G.B Rossi Hospital, Verona, with a 1.5 T Symphony Maestro
Class scanner (Siemens, Germany, Enlargen). The Brain CT was
normal, while MRI scan (Figures 1A–E) revealed an ovoid area
of hyperintensity on T2-weighted and FLAIR images in the
central part of the SCC. On diffusion weighted images the
lesion showed high intensity of the signal with a low ADC
value in comparison to the other components of the corpus
callosum. After intravenous injection of paramagnetic contrast
agent (Gadovist, 7 ml) no enhancement was detected. The
radiological ﬁndings were therefore consistent with a MERS
diagnosis even if the whole clinical picture seemed to be more
severe than those reported nowadays in the literature.
On day 5, organ failure signs (blood pressure 170/110 mm
/Hg; heart rate 136 bpm; BT 38.7°C; CPK 10.535 U/L) suggested
the possible presence of Neuroleptic Malignant Syndrome
(NMS). The patient was transferred to ICU, where deep
sedation (midazolam, propofol) was started, allowing an
adequate treatment of concomitant organic disorders. During
the following days, the hypothesis of NMS was ruled out, and
intensive hydration and urine alkalizing administration
progressively reduced indexes of muscular damage (the rise of
which could be ascribed to agitation and/or ADR). On day 15,
the patient was afebrile, hemodynamically stable, awake but
delusional, and not fully oriented. Psychomotor agitation was
absent, and the patient was moved back to the psychiatric unit. A
follow-up MRI performed 2 weeks after the ﬁrst scan showed the
complete vanishing of the lesion in the SCC, both in T2-weighted
and in particular DWI sequences (Figure 1F). During following
days, the patient became progressively more oriented and less
delirious until day 32, when the patient was discharged on stable
treatment with olanzapine and valproic acid.February 2020 | Volume 11 | Article 79
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The case presented here may be, to our knowledge, the ﬁrst report of
an overlap of two rare conditions: MERS and delirious mania.
According to the clinical and radiological ﬁndings, we have
considered several differential diagnoses, such as infection-related
MERS, acute disseminated encephalomyelitis (ADEM) clinical
onset, paraneoplastic syndrome, metabolic disorder, NMS, and
ADR. The clinical examinations and investigations performed
during the hospitalization ruled out the majority of these
diagnoses: infection indexes were negative, the splenial lesion
disappeared in 10 days thus excluding ADEM, and the other
clinical examinations and investigations were not consistent with
paraneoplastic syndrome, metabolic disorder (such as acute
porphyria or severe acute hyponatremia) or NMS, however, a
speciﬁc diagnosis was not reached. An interesting hypothesis,
needing further studies to be conﬁrmed, is that the known anti-
inﬂammatory (19–21), neuroprotective (22, 23) (possibly due to
antioxidant activity) and immunomodulatory (23) effects of
propofol could have contributed to MERS rapid resolution and
clinical improvement. Although MERS pathophysiology is not
completely understood, some hypotheses claim oxidative stress
and intramyelinic oedema as two possible mechanisms (24, 25).
Therefore, antioxidant and anti-inﬂammatory effects could possibly
represent a focused treatment forMERS syndromes. Moreover, little
is known about speciﬁc radiological features of the manic state, and
the corpus callosum has been described to be largely involved inFrontiers in Psychiatry | www.frontiersin.org 3bipolar disorder (BD) and schizophrenia (26–29) possibly
representing a marker of vulnerability for these disorders (30, 31).
Kobata et al. and Bulakasi et al. (32, 33) reported patients
developing a reversible lesion of the SCC following rotavirus
infection and inﬂuenza-associated encephalitis/encephalopathy
manifesting confusion, agitation, and disorientation. In all the
described cases, patients recovered in 4 to 9 days, and SCC lesions
self-resolved without any life-threatening consequence.
Furthermore, the authors speculated that cytotoxic edema was
the major factor in the development of the encephalopathy and
SCC lesion suggesting that an infarction would be otherwise
irreversible and not consistent with the rapid self-recovery. In
the report of Merizalde et al. (10) a bipolar patient developed a
reversible lesion in the SCC due to the interruption of a lithium
and oxcarbazepine based therapy. However, the patient described
in our case developed a similar symptomatology even though no
lithium/oxcarbazepine therapy was abruptly interrupted.
Similarly, in the case report of Maeda and colleagues (34) a
patient diagnosed with a major depressive disorder suffered
from a focal lesion in the SCC subsequent to the administration
of antiepileptic medication. Notably, as previously mentioned and
speculated by other authors (32, 33), Maeda and colleagues
suggested that reversible SCC lesions are probably caused by
cytotoxic edemas. All the presented cases suggest that reversible
lesions of the SCC can emerge from multiple causes (e.g. rotavirus
infection, lithium withdrawal, administration of epileptic drugs)
potentially giving rise to similar symptoms. The commonFIGURE 1 | Transient focal lesion in the SCC. Coronal and axial T2-weighted images (A, B) and axial FLAIR (C) showed an oval hyperintense focal lesion in the
SCC. On axial DWI (D) the lesion is hyperintense with low values on the ADC map (E). After 2 weeks, the lesion is no longer detectable on DWI (F).February 2020 | Volume 11 | Article 79
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resolving in 2 weeks with a good prognosis (10). However, in
our report, the patient's clinical condition diverged from most
cases present in the literature, requiring intensive care and deep
sedation. This ﬁnding is especially important because, in contrast
with our ﬁndings, in all the previously mentioned reports patients'
clinical conditions recovered quickly following a good prognosis in
accordance with Hoshino's guidelines (4).
Concerning BD and mania, structural and diffusion MRI
studies have widely reported abnormalities in volume, signal
intensity, and microstructure of the corpus callosum, suggesting
altered inter-hemispheric connectivity as a possible marker of
illness, potentially leading to cognitive and emotional deﬁcits
(35). Our group found signiﬁcantly increased ADC values in the
anterior body and SCC in a sample of BD compared to healthy
controls (31), suggesting microstructural anomalies speciﬁcally
in the right hemisphere, and in another work, we applied Tract-
Based Spatial Statistics (TBSS) in samples of BD and
schizophrenia patients, conﬁrming that fractional anisotropy
(FA) is decreased in the fronto-temporal and callosal networks
of these patients (36). Moreover, our group has also shown that
alterations of the corpus callosum and impaired brain
interhemispheric communication are involved in the
pathophysiology and cognitive deﬁcits present in BD (27, 28).
Recently a large tractography study conﬁrmed low FA in
white matter tracts, including the corpus callosum, with more
severe biological abnormality in the subgroup of patients with
psychosis. This provided additional evidence for the
interhemispheric disconnectivity theory of BD, ﬁrst described
by Pettigrew and Miller (37). These authors considered slow
interhemispheric switching as a marker of BD, and suggested
that the right hemisphere is predominantly involved in
depression and the left in mania. More generally, the
disconnectivity hypothesis suggests that psychotic illnesses
arise not from regionally speciﬁc focal pathophysiology in the
brain, but rather from impaired integration between
neuroanatomical regions (38). This impairment may be due to
damage of axonal membranes or to axonal demyelination (39).
According to the evidence, brain white matter and in particular
the corpus callosum is considered a marker of vulnerability in
patients with psychotic BD. Notably, other studies also found a
generalized reduction in mean FA in the SCC, left cingulum, and
in the anterior part of the left arcuate fasciculus in patients with
BD, ultimately affecting interhemispheric communication (40).
Future studies correlating MRI data with cognitive and clinical
assessments are warranted to understand the speciﬁc functional
correlates of these white matter deﬁcits in BD (41).CONCLUSION
We describe a rare case of delirious mania associated with reversible
splenial lesion. The clinical-radiological features are consistent with
Hoshino's diagnostic criteria for MERS (4). MERS is considered a
self-resolving clinic-radiological syndrome that is not a life-
threatening condition (2). This is in contrast to our report ofFrontiers in Psychiatry | www.frontiersin.org 4delirious mania associated with a reversible splenial lesion.
Delirious mania is in fact itself a life-threatening condition (12–
14) and the above described organ failure signs were consistent with
this interpretation. Moreover, this case supports the limited
evidence (17, 18) for propofol-mediated deep sedation to treat
life-threatening mania. This is also one of the few published
reports describing possible radiological correlates of acute mania
with MRI performed during the acute episode (10, 30, 31). Notably,
Blumberg and colleagues studied acute mania and found a
hyperactivation of the left caudate and anterior cingulate cortex,
supporting the disconnection proposed by Pettigrew andMiller (37,
42). More evidence is now needed to: (i) better identify neural
markers of acute mania; (ii) the role of the corpus callosum in the
pathogenesis of BD; and (iii) a possible hemispheric specialization
involved in manic symptoms. The opportunity of performing MRI
scanning during the acute phase of a delirious mania has given us
the possibility of achieving valuable data for further research in this
ﬁeld, allowing the connection between speciﬁc clinical signs and
MRI imaging in a rare condition. The speciﬁc interaction between a
localized lesion in the SCC, the evident clinical signs and symptoms,
and the patient's psychiatric background remain unclear, and this
report raises more questions than it answers. More work is needed
to improve knowledge on the pathophysiology of mania.DATA AVAILABILITY STATEMENT
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